137 related articles for article (PubMed ID: 2858546)
21. Transit of pharmaceutical dosage forms through the small intestine.
Davis SS; Hardy JG; Fara JW
Gut; 1986 Aug; 27(8):886-92. PubMed ID: 3732895
[TBL] [Abstract][Full Text] [Related]
22. Effect of bolus composition on esophageal transit: concise communication.
Fisher RS; Malmud LS; Applegate G; Rock E; Lorber SH
J Nucl Med; 1982 Oct; 23(10):878-82. PubMed ID: 7119880
[TBL] [Abstract][Full Text] [Related]
23. Mass variation tests for coating tablets and hard capsules: rational application of mass variation tests.
Katori N; Aoyagi N; Kojima S
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1176-80. PubMed ID: 12237532
[TBL] [Abstract][Full Text] [Related]
24. Crushing tablets or opening capsules: many uncertainties, some established dangers.
Prescrire Int; 2014 Sep; 23(152):209-11, 213-4. PubMed ID: 25325120
[TBL] [Abstract][Full Text] [Related]
25. The effect of glucagon on the swallowing of capsules.
Channer KS; Bolton R; Al-Hilli S; Nakielny R; Virjee JP
Br J Clin Pharmacol; 1983 Oct; 16(4):456-8. PubMed ID: 6626442
[TBL] [Abstract][Full Text] [Related]
26. Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz).
Gao JZh; Hussain MA; Motheram R; Gray DA; Benedek IH; Fiske WD; Doll WJ; Sandefer E; Page RC; Digenis GA
J Pharm Sci; 2007 Nov; 96(11):2970-7. PubMed ID: 17542016
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.
Jaspersen D
Drug Saf; 2000 Mar; 22(3):237-49. PubMed ID: 10738847
[TBL] [Abstract][Full Text] [Related]
28. Swallowing Tablets and Capsules Increases the Risk of Penetration and Aspiration in Patients with Stroke-Induced Dysphagia.
Schiele JT; Penner H; Schneider H; Quinzler R; Reich G; Wezler N; Micol W; Oster P; Haefeli WE
Dysphagia; 2015 Oct; 30(5):571-82. PubMed ID: 26205435
[TBL] [Abstract][Full Text] [Related]
29. Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules.
Nikolova Z; Peng B; Hubert M; Sieberling M; Keller U; Ho YY; Schran H; Capdeville R
Cancer Chemother Pharmacol; 2004 May; 53(5):433-8. PubMed ID: 15132131
[TBL] [Abstract][Full Text] [Related]
30. Esophageal passage of iodine-131 capsules.
Garcia-Peña E; Caravalho J; Watkins JW; Leifer ES
J Nucl Med Technol; 1997 Mar; 25(1):55-8. PubMed ID: 9239606
[TBL] [Abstract][Full Text] [Related]
31. Before crushing a tablet or opening a capsule...
Prescrire Int; 2014 Sep; 23(152):211. PubMed ID: 25325121
[No Abstract] [Full Text] [Related]
32. Gastroretentive dosage forms.
Moës AJ
Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of esophageal transit of tablets and capsules in 30 cats.
Westfall DS; Twedt DC; Steyn PF; Oberhauser EB; VanCleave JW
J Vet Intern Med; 2001; 15(5):467-70. PubMed ID: 11596734
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of capsule swallowing by healthy young men and capsule transit time from the mouth to the stomach.
Chisaka H; Matsushima Y; Wada F; Saeki S; Hachisuka K
Dysphagia; 2006 Oct; 21(4):275-9. PubMed ID: 17216387
[TBL] [Abstract][Full Text] [Related]
35. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
Shah J; Wesnes KA; Kovelesky RA; Henney HR
Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
[TBL] [Abstract][Full Text] [Related]
36. What happens to tablets and capsules in the stomach: endoscopic comparison of disintegration and dispersion characteristics of two microencapsulated potassium formulations.
Graham DY; Smith JL; Bouvet AA
J Pharm Sci; 1990 May; 79(5):420-4. PubMed ID: 2352162
[TBL] [Abstract][Full Text] [Related]
37. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers.
Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS
Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905
[TBL] [Abstract][Full Text] [Related]
38. Development of a method for study of the tendency of drug products to adhere to the esophagus.
Marvola M; Vahervuo K; Sothmann A; Marttila E; Rajaniemi M
J Pharm Sci; 1982 Sep; 71(9):975-7. PubMed ID: 7131280
[TBL] [Abstract][Full Text] [Related]
39. A comparison of barium swallow and erect esophageal transit scintigraphy following balloon dilatation for achalasia.
Chawda SJ; Watura R; Adams H; Smith PM
Dis Esophagus; 1998 Jul; 11(3):181-7; discussion 187-8. PubMed ID: 9844801
[TBL] [Abstract][Full Text] [Related]
40. Oesophageal motor function before and after healing of oesophagitis.
Singh P; Adamopoulos A; Taylor RH; Colin-Jones DG
Gut; 1992 Dec; 33(12):1590-6. PubMed ID: 1487159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
